Vectorite Biomedical (ROCO:4170) Interest Expense : NT$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Vectorite Biomedical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vectorite Biomedical's interest expense for the six months ended in Dec. 2024 was NT$ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Vectorite Biomedical's Operating Income for the six months ended in Dec. 2024 was NT$ -10.76 Mil. Vectorite Biomedical's Interest Expense for the six months ended in Dec. 2024 was NT$ 0.00 Mil. Vectorite Biomedical has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Vectorite Biomedical Interest Expense Historical Data

The historical data trend for Vectorite Biomedical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectorite Biomedical Interest Expense Chart

Vectorite Biomedical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.11

Vectorite Biomedical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Vectorite Biomedical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

Vectorite Biomedical (ROCO:4170) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vectorite Biomedical's Interest Expense for the six months ended in Dec. 2024 was NT$0.00 Mil. Its Operating Income for the six months ended in Dec. 2024 was NT$-10.76 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was NT$0.00 Mil.

Vectorite Biomedical's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Vectorite Biomedical had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Vectorite Biomedical Inc has no debt.

Vectorite Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectorite Biomedical Inc (ROCO:4170) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 97, Section 1, Xintai 5th Road, 6th Floor, Floor-11, Yuzhi District, New Taipei City, Taipei, TWN, 22175

Website

https://www.vectorite.com.tw

Vectorite Biomedical Inc is a Taiwan-based biotechnology research and development, cell product (preparation) manufacturing and immune cell collection and storage business.

Vectorite Biomedical Headlines

No Headlines